Alzheimer's: The United States authorizes a long-awaited new treatment

Alzheimer’s: The United States Authorizes a Long-Awaited New Treatment

REVOLUTION: This drug, marketed under the name Leqembi, is recommended for patients who have not yet reached an advanced stage of the disease Good news for millions of patients. US health authorities on Friday authorized a new Alzheimer’s drug aimed at reducing cognitive decline in patients suffering from this neurodegenerative disease, a much-awaited treatment after the failed launch of a previous […]

Continue Reading